clinical note writing pharmacy department dale tucker, rph, bcps elizabeth cincotta, pharmd detroit...
TRANSCRIPT
Clinical Note Writing
Pharmacy DepartmentDale Tucker, RPh, BCPS
Elizabeth Cincotta, PharmD
Detroit Medical CenterLast Updated July 2005 by Julie Berman (DRH), Albert Bajjoka (HVSH),
May Saba (CHM), Kim Tsilimingras (SGH), & Dale Tucker (HUH)
Amount of detail may vary from site to site
Goals and Objectives
Goal: To orient the pharmacist to writing consistently accurate and clear notes in patient charts.
Objective: To give the pharmacist experience in note writing in the chart and have the notes formally reviewed in conjunction with pharmacokinetic and anticoagulation instruction.
Amount of detail may vary from site to site
Introduction
Why write notes?Note variations Pharmacokinetics Anticoagulation
Note types First notes Follow-up notes
Note etiquetteNote QAs
Amount of detail may vary from site to site
Why Write Notes?
Define/communicate issues
Discuss current and alternative therapies
Determine drug duration of therapy
Suggest drug changes
Inform about patient education or medication adherence history
Amount of detail may vary from site to site
Types of Notes
Pharmacokinetic notes
Anticoagulation notes
Patient education notes
Renal dosing notes
TPN notes
Other medication notes
Amount of detail may vary from site to site
General Breakdown of Notes
First notes Include pertinent
patient history Include reason for
consult Include related lab
values, vital signs, and culture results
Assess medication regimen
Make recommendations
Follow-up notes Assess duration of
therapy Update related lab
values and culture results
Assess medication regimen
Make recommendations
Amount of detail may vary from site to site
All First NotesSome sites may have a standardized sticker available
Date and timeHeader: Pharmacy Services or Anticoagulation Dosing Service, etc.Patient demographics (age, allergy status, height, weight) and historyMedications as appropriateReason for consult or indication for therapy being monitoredPertinent lab values (BUN/Cr, CBC, cultures, etc.) Plan and/or a recommendationSignature and pager number
Amount of detail may vary from site to site
Pharmacokinetic First Notes Some sites may have a standardized sticker available
Include patient’s temperature (Tmax, Tcurrent)On ICU and BMT units include I/OsInclude culture resultsInclude pharmacokinetic parameters for aminoglycoside drugsInclude desired goal levels and plan or need for monitoring levelsAddress any other antibiotics the patient is taking as per site requirementsIndicate that primary team is to monitor for signs/symptoms of nephrotoxicity or ototoxicity
Amount of detail may vary from site to site
Anticoagulation First Notes Some sites may have a standardized sticker available
Include baseline or most recent as well as current INR/PT and/or aPTT if possible
Assess potential drug and dietary interactions
Include target values for INR and/or aPTT
Indicate when to monitor next INR or aPTT
Address all anticoagulants the patient is taking
Indicate MD/RN to monitor for signs/symptoms of bleeding
Amount of detail may vary from site to site
All Follow-up Notes Some sites may have a standardized sticker available
Include reason for consult or indication for therapy being monitored Note: The reason for therapy may change and needs
to be evaluated with each note written, i.e., rule out pneumonia is not appropriate a week after the initial note
Indicate day of therapy and assess duration of therapyInclude updated pertinent lab values Include a plan and/or a recommendation
Amount of detail may vary from site to site
Pharmacokinetic F/U Notes Some sites may have a standardized sticker available
Include patient’s temperatureUpdate culture resultsReport any drug levels with an interpretation of them and/or a recommended actionIndicate the times of the levels with reference to the time the dose was givenOn ICU and BMT units include I/OsIndicate that primary team is to monitor for signs/symptoms of nephrotoxicity or ototoxicity
Amount of detail may vary from site to site
Anticoagulation F/U Notes Some sites may have a standardized sticker available
Include target values for INR and/or aPTT
Indicate the most recent CBC
Indicate plan for transition to oral warfarin such as DC heparin when INR at goal X2 days
Indicate primary team is to monitor for signs/symptoms of bleeding
Amount of detail may vary from site to site
Note the Common Threads
Always be organized and neat
Always include reason for the consult or indication for therapy being monitored
Always update any lab values or culture results
Always include a plan and/or a recommendation
Amount of detail may vary from site to site
“Political Correctness”
Use notes to communicate information pertinent to the care of the patientUse only approved abbreviations when writing orders or notesDo not argue a point in the notes: CALL THE PHYSICIANAvoid judgmental statementsNever write a note when emotionally upset
Amount of detail may vary from site to site
DMC: Unsafe AbbreviationsDO NOT USE Intended Meaning USE THIS INSTEAD
U or IU units Use “units” or “international units”
µg micrograms Use “mcg” or “micrograms”
Lack of leading zero (.5 mg)
0.5 mg Always use leading zeros when the dose is less than a whole unit
Use of trailing zero (5.0 mg)
5 mg Never use trailing zeros for doses expressed in whole numbers
TIW Three times a week Use “three times a week”
° symbol hours Use “hour, hr or hrs”
Q.D. Once daily Use “daily”
Q.O.D. Every other day Use “every other day”
MS, MSO4 , Mg SO4 Morphine sulfate or Magnesium sulfate
Use “morphine sulfate, magnesium sulfate”
Amount of detail may vary from site to site
Word Choices
Recommend When you are 100% sure of your
recommendation
Suggest When fairly certain of your decision
Consider When you are even slightly hesitant about
your recommendation
Amount of detail may vary from site to site
Word Choices
DON’T USE Toxic Supratherapeutic Above therapeutic
range Maximum High Bad Wrong
USE Above goal for this
patient and indication Not within desired
range for this patient
Amount of detail may vary from site to site
Word Choices
DON’T USE Subtherapeutic Below therapeutic
range Minimum Low Bad Wrong
USE Below goal for the
patient and indication Not within desired
range for this patient
Amount of detail may vary from site to site
Word Choices
DON’T USE Abbreviations for
terms (drug names, pharmacokinetic parameters) that are not approved by the hospital or that may have other explanations
Amount of detail may vary from site to site
Word Choices
DON’T USE Exact number for an
estimated value (i.e., CrCl=46ml/min)
USE Ranges (i.e., CrCl=40-
60ml/min) Approximately
36ml/min
Remember, calculations are an estimate!
Amount of detail may vary from site to site
Clinical Quality Assessment
To give a peer review of pharmacist communication in the chart and on the PMR
To evaluate the content of notes
To evaluate pharmacy monitoring record (PMR) for completeness
To compile data quarterly as a clinical quality indicator
Amount of detail may vary from site to site
Peer Reviewed Quality Assessment
Everyone who writes notes Has their notes evaluated by other clinical
pharmacists Is expected to evaluate and submit a QA of
other clinical pharmacist’s notes (~10/month) Submits QAs of pharmacist and non-pharmacist
orders when discrepancies are noted such as “U” written instead of “units”
NOTE: submit QA for correct notes, too!
Amount of detail may vary from site to site
QA Monitoring Form
Amount of detail may vary from site to site
In Conclusion
Be clear!
Be accurate!
Your notes are being read!